The common types of IVD tests include immunoassays, molecular diagnostics, and clinical chemistry tests. Such tests play a crucial role in healthcare by providing timely and accurate information for medical decision-making. IVD solutions are essential tools for screening, diagnosing, and monitoring diseases, ultimately contributing to improved patient outcomes and public health.

In Vitro Diagnostics Market Segments

Based on test type, the market is segmented into laboratory and point-of-care testing.

The laboratory testing segment led the market, capturing the largest revenue share of 85% in 2024.

The point-of-care segment is anticipated to show the highest annual growth rate of 8% during the forecast period.

Based on type of offering, the market is segmented into reagents, instruments, and services.

The reagents segment led the in vitro diagnostics market, capturing the largest revenue share of 75% in 2024.

Owing to the intricacies and complexities associated with the development of in vitro diagnostic solutions, this trend is expected to remain same during the forecast period.

Based on type of technology, the market is segmented into clinical chemistry, hematology, immunoassay, molecular diagnostics, and others.

The type of technology segment led the in vitro diagnostics market, capturing the largest revenue share of 34% in 2024.

The molecular diagnostics segment is anticipated to show an annual growth rate of 6.2% during the forecast period.

Based on therapeutic areas, the market is segmented into autoimmune diseases, cardiovascular disorders, diabetes, infectious diseases, renal disorders, oncological disorders, and others.

The infectious disease segment led the market, capturing the largest revenue share of 41% in 2024.

The cardiology segment is anticipated to show the highest annual growth rate of 5.6%, during the forecast period.

Based on end users, the market is segmented into hospitals, laboratories, and other end users.

The hospitals segment led the market, capturing the largest revenue share of 48% in 2024.

The hospitals segment is anticipated to show an annual growth rate of 5.5% during the forecast period and is expected to hold the majority share of the market in the future, as well.

Based on geographical regions, the market is segmented into North America, Europe, Asia, Latin America, Middle East and North Africa, and Rest of the World

North America dominated the market and accounted for the largest revenue share of 39.0% in 2024.

In Asia, the market is anticipated to demonstrate lucrative growth during the forecast period.

In Vitro Diagnostics Market Regional Outlook

Based on the key geographical regions, the market can be segmented into three major regions, including North America, Europe, Asia-Pacific and rest of the world. Led by the US, North America is anticipated to capture the majority share of the market in 2024, and this trend is likely to remain unchanged during the forecast period.

Further, the demand for in vitro diagnostic solutions is growing at a faster rate in Asia, owing to the increasing government initiatives in developing countries. The government is encouraging solution providers to develop in vitro diagnostic solutions in order to cater to the growing burden of patients suffering from illnesses.

Key Report Takeaways

The in vitro diagnostics market landscape is well distributed among leading players that utilize various types of advanced diagnostic technologies in order to cater to a variety of diagnostic applications

Majority of the IVD solutions employ the use of immunoassay and molecular diagnostic technologies in order to detect and diagnose various disease conditions, such as infectious diseases and oncological disorders

Industry players are making extensive efforts to expand their existing capacities, capabilities and facilities to augment their In vitro diagnostic solutions portfolio

In vitro diagnostics is a well-established market wherein the solution providers are currently focusing on innovation and technological advancements to enhance diagnostic accuracy, speed, and accessibility

The in vitro diagnostics market is fueled by growing awareness towards preventive healthcare, however factors, such as addressing regulatory complexities remain significant hurdles for industry players

Driven by the increasing prevalence of chronic disorders across the globe, we anticipate the global market is expected to reach nearly USD 190 billion by 2035

The anticipated future opportunity in the market is expected to be well distributed across multiple segments, such as therapeutic areas, test type and end users

Key Players

Examples of key companies engaged in the In Vitro Diagnostics Market (which have also been profiled in this market report; the complete list of companies is available in the full report) include, Abbott Laboratories, Agilent Technologies Technologies, Becton Dickinson, bioMrieux, Bio-Rad, Danaher Corporation, DiaSorin, Exact Sciences, Fujifilm, Gold Standard Diagnostics, Grifols, Hologic, Illumina, LabCorp, Qiagen, Quest Diagnostics, QuidelOrtho, Roche, Siemens Healthineers, Sysmex, Thermo Fisher Scientific and Werfen.

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Email: sales@rootsanalysis.com